In addition to overall DFS for all breast cancer cases, low ERRα and high NURR1 expression was associated with improved survival in patients with lymph node positive tumors (p = 0.019 and p = 0.007, respectively, Table 2). This evidence concerns the gene NR4A2 and breast carcinoma.